Phathom Pharmaceuticals initiated at Market Perform; PT set at $10
Leerink Partners initiated Phathom Pharmaceuticals with a Market Perform rating and announced a $10.00 per-share price target, per TradingView News.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.